Novo Nordisk Boosts Outlook as Weight-Loss Pill Sales Accelerate in U.S.
Novo Nordisk raised its full-year financial outlook after reporting stronger-than-expected first-quarter earnings, underscoring continued momentum in the global
Novo Nordisk raised its full-year financial outlook after reporting stronger-than-expected first-quarter earnings, underscoring continued momentum in the global